Trial
NCT06707896
TCR1020-CD8 T Cells in KRAS-mutated Cancers
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
Stand Up To Cancer; Lustgarten Foundation
Condition
Metastatic Pancreatic Adenocarcinoma
Intervention
TCR1020-CD8 T cells
Why stopped
Administrative decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-06-25